Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Personalized Ex Vivo Drug Screening and Genomics Profiling to Guide Individualized Treatments for Children With Relapsed or Refractory Solid Tumors and Leukemias

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03860376
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:10.845810+00:00
Published At
2023-05-10T00:00:00+00:00
Record Updated At
2023-05-10
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Recurrent Childhood Acute Myeloid Leukemia", "Recurrent Childhood Acute Lymphoblastic Leukemia", "Recurrent Childhood Large Cell Lymphoma", "Refractory Childhood Acute Lymphoblastic Leukemia", "Refractory Childhood Hodgkin Lymphoma", "Refractory Childhood Malignant Germ Cell Neoplasm", "Recurrent Childhood Brain Tumor", "Recurrent Childhood Brainstem Glioma", "Recurrent Childhood Rhabdomyosarcoma", "Recurrent Childhood Soft Tissue Sarcoma", "Recurrent Childhood Ependymoma", "Recurrent Childhood Lymphoblastic Lymphoma", "Recurrent Childhood Gliosarcoma", "Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-05-10"
protocolSection.identificationModule.nctId
"NCT03860376"
protocolSection.identificationModule.officialTitle
"Personalized Ex Vivo Drug Screening and Genomics Profiling to Guide Individualized Treatments for Children With Relapsed or Refractory Solid Tumors and Leukemias"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Recurrent Childhood Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Acute Lymphoblastic Leukemia (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Refractory Childhood Acute Lymphoblastic Leukemia (protocolSection.conditionsModule.conditions)
  • Refractory Childhood Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Refractory Childhood Malignant Germ Cell Neoplasm (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Brain Tumor (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Brainstem Glioma (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Rhabdomyosarcoma (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Soft Tissue Sarcoma (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Ependymoma (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Lymphoblastic Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Gliosarcoma (protocolSection.conditionsModule.conditions)
  • Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.